MedTrace Logo

Systane® Hydration PF and Systane® Hydration Preserved

NCT05932238 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2024-09-19

No results posted yet for this study

Summary

The purpose of this post-market clinical follow-up (PMCF) study is to assess the performance and safety of Systane Hydration Preservative Free (PF) in subjects experiencing dry eye symptoms (Group 1) and in contact lens (CL) wearers experiencing discomfort due to CL-related dryness (Group 2) and also Systane Hydration Preserved in CL wearers experiencing discomfort due to CL-related dryness (Group 3). Statistical analyses will be presented by group.

Conditions

  • Dry Eye

Interventions

OTHER

Polyethylene glycol 400 and propylene glycol solution/drops - Preservative Free (PF)

commercially available eye drops

OTHER

Polyethylene glycol 400 and propylene glycol solution/drops - Preserved

commercially available eye drops

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Clinical Lead, Vision Care · Alcon Research, LLC

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-06
Primary Completion
2024-09-05
Completion
2024-09-05

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05932238 on ClinicalTrials.gov